European Gene Therapy Markets

European Gene Therapy Markets

 

RELEASE DATE
03-Dec-2002
REGION
Europe
Research Code: B112-01-00-00-00
SKU: HC01008-EU-MR_04950
AvailableYesPDF Download

$4,950.00

Special Price $3,712.50 save 25 %

In stock
SKU
HC01008-EU-MR_04950

$4,950.00

$3,712.50save 25 %

DownloadLink
ENQUIRE NOW

Description

Cell Therapies; Gene Therapies: corrective gene delivery, therapeutic gene delivery, ribozymes, antisense, prodrug + enzyme delivery. Not DNA vaccines (therapeutic or prophylactic). In relation to the European market; in particular, the way in which these therapies would be applied to European therapeutic methodology.

Table of Contents

Market Overview

  • Introduction and Presentation

A New Definition of Medicine

  • A Brief History
  • Market Definition
  • The European Perspective
  • Glossary of Terms

Technology Overview

  • Viral Vector Technology
  • Non-Viral Vector Technology
  • Gene-Related Therapeutic Technology

Corporate Strategy

Product Strategy

  • Defining the Corporate Strategy
  • Commercial Strategy
  • Development Strategy
  • Patent Strategy
  • Public Relations Strategy

Market Overview

Forecasts for the Total Gene Therapy Market

Market Overview

Forecasts for the Cancer Gene Therapy Market

Market Overview

Forecasts for the Vascular Diseases Gene Therapy Market

Market Overview

Forecasts for the Monogenic Disease Gene Therapy Market

Frost & Sullivan 2002 ME Awards for Gene Therapy

Related Research
Cell Therapies; Gene Therapies: corrective gene delivery, therapeutic gene delivery, ribozymes, antisense, prodrug + enzyme delivery. Not DNA vaccines (therapeutic or prophylactic). In relation to the European market; in particular, the way in which these therapies would be applied to European therapeutic methodology.
More Information
No Index Yes
Podcast No
Industries Healthcare
WIP Number B112-01-00-00-00
Is Prebook No